AM-2201 is a potent agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 1.0nM at CB1 and 2.6nM at CB2. AM-2201 is more potent than phytocannabinoid Δ9-tetrahydrocannabinol.
Potent agonist at both CB1 and CB2 with moderate selectivity for CB1
The Journal of pharmacology and experimental therapeutics, 367(3), 543-550 (2018-09-30)
Novel synthetic cannabinoids are appearing in recreational drug markets worldwide. Pharmacological characterization of these new drugs is needed to inform clinicians, toxicologists, and policy makers who monitor public health. [1-(5-Fluoropentyl)-1H-indol-3-yl](1-naphthyl)methanone (AM-2201) is an abused synthetic cannabinoid that was initially created
Journal of mass spectrometry : JMS, 47(7), 825-835 (2012-07-14)
The analysis of synthetic cannabinoids in human matrices is of particular importance in the fields of forensic and clinical toxicology since cannabis users partly shift to the consumption of 'herbal mixtures' as a legal alternative to cannabis products in order
New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites.